Key Takeaways
- About 19.1% of U.S. adults had an anxiety disorder in the past year, and anxiety disorders are the most common mental disorders in the United States. An estimated 21.0 million adults (8.3%) had a major depressive episode in 2021.[4][3]
- For generalized anxiety disorder, NICE recommends an SSRI first if you choose medication, then another SSRI or an SNRI if that does not work.[8] For depression, guidelines offer psychotherapy or an antidepressant as first-line choices, and the APA recommends CBT or interpersonal therapy plus an antidepressant when combined treatment is chosen.[1][2]
- If an antidepressant is going to work, NICE says an effect is usually seen within 4 weeks. Early side effects often come first, so patience and communication with your prescriber are essential.[2]
- Never stop an antidepressant abruptly. FDA labels advise reducing the dose gradually, and NICE describes tapering in stages, with your prescriber guiding the plan.[9][2]
- If you or someone you know is experiencing suicidal thoughts, call or text 988 (Suicide & Crisis Lifeline) immediately. Treat this as a medical emergency.[6]
If you're reading this, there's a good chance you or someone you care about is navigating life with anxiety, depression, or both. I want to start with one point: seeking help is not a sign of weakness. It is, in fact, one of the most courageous and practical things a person can do. These conditions are medical, shaped by brain chemistry, genetics, and life circumstances, and they deserve the same thoughtful, evidence-based treatment we give any other medical condition.
An estimated 19.1% of U.S. adults had an anxiety disorder in the past year, and NIMH notes that, combined, anxiety disorders are the most common mental disorders in the United States.[4] An estimated 21.0 million U.S. adults, or 8.3% of all adults, had at least one major depressive episode in 2021.[3] Many still go without care: NIMH estimates that 61.0% of adults with a major depressive episode received treatment in the past year, which leaves a large group untreated.[3] The gap between suffering and treatment is one of the most significant public health challenges of our time.
What makes these conditions particularly complex is how often they overlap. In my clinical practice, I often see anxiety and depression together, and that overlap shapes how we approach treatment.
This guide is written for patients who are already taking medication for anxiety or depression, those considering starting, and anyone who wants to understand the scene of treatment in 2025–2026. My goal is to provide you with the same level of information I would give a family member: honest, thorough, and free of judgment.
Understanding Anxiety and Depression
Anxiety and depression are distinct conditions, but they share enough biological territory that understanding one helps illuminate the other.
Depression is characterized by persistent low mood, loss of interest or pleasure in activities that were once enjoyable, changes in sleep and appetite, difficulty concentrating, fatigue, feelings of worthlessness or excessive guilt, and, in severe cases, thoughts of death or suicide. It is not "feeling sad" any more than pneumonia is "having a cough." Depression involves measurable changes in brain function, neurotransmitter activity, and even brain structure over time.
Anxiety disorders encompass several conditions, including generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and specific phobias. They are unified by excessive fear or worry that is disproportionate to the actual situation. Physical symptoms are prominent: racing heart, muscle tension, shortness of breath, gastrointestinal distress, and insomnia. The experience of clinical anxiety goes far beyond ordinary worry; it is persistent, intrusive, and functionally impairing.
The Neurobiology (Without Oversimplifying)
You've likely heard that depression is caused by a "chemical imbalance," specifically low serotonin. That narrative, while it helped reduce stigma, is an oversimplification. The truth is more layered. Both anxiety and depression involve dysregulation across multiple neurotransmitter systems (serotonin, norepinephrine, dopamine, GABA, and glutamate), as well as dysfunction in neural circuits connecting the prefrontal cortex, amygdala, and hippocampus. Inflammation, stress hormones (cortisol), genetics, and life experiences all play contributing roles.
What this means practically: medication works not because it "fills a gap" in a single chemical, but because it modulates the way neurons communicate, gradually allowing your brain's regulatory systems to reset. It's why these medications take weeks to work. They're not filling a tank; they're retraining a system.
What the Latest Guidelines Say (2025–2026)
The treatment of anxiety and depression has evolved meaningfully over the past several years. Here is where the evidence stands as of early 2026.
The American Psychological Association's clinical practice guideline for depression recommends that clinicians offer adults either psychotherapy or a second-generation antidepressant, chosen through shared decision-making. If combined treatment is considered, the panel recommends cognitive-behavioral therapy (CBT) or interpersonal psychotherapy (IPT) plus a second-generation antidepressant.[1] In 2025, the APA Board of Directors appointed a multidisciplinary panel to update the 2019 guideline.[1]
The UK's National Institute for Health and Care Excellence (NICE) guideline NG222 for depression in adults, last reviewed in January 2026, asks clinicians to discuss treatment options and reach a shared decision that matches each person's clinical needs and preferences. Its first-line options include guided self-help, group exercise, several psychotherapies, and antidepressant medication.[2]
Key consensus points across current guidelines:
- For generalized anxiety disorder, NICE recommends offering an SSRI first if a person chooses drug treatment (it suggests sertraline first because it is the most cost-effective), and an alternative SSRI or an SNRI if that is ineffective.[8] A 2019 network meta-analysis of 89 trials found duloxetine, pregabalin, venlafaxine, and escitalopram more efficacious than placebo with relatively good acceptability.[7]
- For depression, NICE describes SSRIs as generally well tolerated with a good safety profile and says they should be considered the first choice for most people.[2]
- For more severe depression, NICE lists a combination of individual CBT and an antidepressant first among its first-line options.[2] For generalized anxiety disorder, NICE cautions that evidence for combination treatments is lacking.[8]
- For depression that has not responded to earlier treatment, options include esketamine nasal spray (Spravato), which is FDA-labeled for treatment-resistant depression in adults either on its own or with an oral antidepressant and is available only through a restricted program under a healthcare provider's supervision,[17] and aripiprazole, which is FDA-labeled as an add-on treatment for major depressive disorder.[18]
- FDA labeling advises reducing antidepressant doses gradually rather than stopping abruptly whenever possible, and NICE advises tapering in stages over time.[9][16][2]
- NICE advises against benzodiazepines for generalized anxiety disorder except as a short-term measure during crises, and benzodiazepine labels carry a boxed warning about abuse, misuse, addiction, dependence, and withdrawal reactions.[8][19]
Common Medications Explained
The following table summarizes the medications I most commonly prescribe or encounter in patients managing anxiety and depression. This represents not an exhaustive formulary, but it covers the agents you are most likely to be taking or to be offered.
| Medication | Class | Typical Uses | Onset Timeline | Key Side Effects |
|---|---|---|---|---|
| Sertraline (Zoloft) | SSRI | FDA-labeled for depression, panic disorder, social anxiety disorder, PTSD, OCD, and PMDD[9]; NICE suggests it first for GAD[8] | Usually within 4 weeks if it is going to work[2] | Nausea, diarrhea, tremor, indigestion, decreased appetite, sweating, ejaculation problems, decreased libido[9] |
| Escitalopram (Lexapro) | SSRI | Depression, GAD[10] | Usually within 4 weeks if it is going to work[2] | Insomnia, nausea, increased sweating, fatigue, sleepiness, decreased libido, delayed ejaculation, difficulty reaching orgasm[10] |
| Fluoxetine (Prozac) | SSRI | Depression, panic disorder, OCD, bulimia; its very long half-life means dose changes take several weeks to be fully reflected[11] | Usually within 4 weeks if it is going to work[2] | Nausea, insomnia, anxiety, nervousness, decreased libido, abnormal dreams[11] |
| Venlafaxine (Effexor XR) | SNRI | Depression, GAD, social anxiety, panic disorder[12] | Usually within 4 weeks if it is going to work[2] | Nausea, sleepiness, dry mouth, sweating, constipation, decreased libido; can raise blood pressure, so the label advises regular monitoring[12]; NICE notes a tendency to cause withdrawal symptoms[8] |
| Duloxetine (Cymbalta) | SNRI | Depression, GAD, diabetic nerve pain, fibromyalgia, chronic musculoskeletal pain[13] | Usually within 4 weeks if it is going to work[2] | Nausea, dry mouth, sleepiness, constipation, decreased appetite, sweating[13] |
| Buspirone (BuSpar) | Non-benzodiazepine anxiolytic | Management of anxiety disorders[14] | Ask your prescriber what to expect | Dizziness, nausea, headache, nervousness, lightheadedness, excitement; lacks the prominent sedation of typical anxiolytics, and the label reports no evidence of tolerance or dependence[14] |
| Bupropion (Wellbutrin XL) | Aminoketone antidepressant | Depression; prevention of seasonal affective disorder[15] | Usually within 4 weeks if it is going to work[2] | Dry mouth, nausea, insomnia, dizziness, agitation, anxiety, tremor; seizure risk is dose-related[15] |
A note on this table: Every patient is different. The "best" medication is the one that adequately treats your symptoms with tolerable side effects, fits your medical history, and aligns with your preferences. What works remarkably well for one person may not be the right fit for another. What this means is why ongoing communication with your prescriber matters so much.
Decision Framework: Routine Refill, Talk to Your Doctor, or Seek Emergency Care
One of the most practical questions patients ask is: "I'm due for a refill. Do I just renew, or should I be scheduling an appointment?" The following framework reflects how I guide patients in clinical practice.
| Scenario | Recommended Action | Rationale |
|---|---|---|
| Stable on current medication: symptoms well controlled, no new side effects, no major life changes | Routine refill, with regular reviews by your prescriber | NICE advises that treatment be reviewed regularly; dosage needs can change over time[2] |
| Partial improvement: feeling somewhat better but still having significant symptoms 4 or more weeks after starting | Schedule an appointment with your prescriber | If an antidepressant is going to work, an effect is usually seen within 4 weeks[2]; you may need a dose adjustment, a switch, an add-on medicine, or therapy |
| New or worsening side effects: sexual side effects, significant weight changes, persistent insomnia, emotional blunting | Contact your prescriber promptly | Side effects can often be managed by adjusting the dose or timing, or by switching medicines. Do not stop medication on your own. |
| Worsening symptoms: increasing anxiety, deepening depression, withdrawal from activities, inability to function at work or home | Urgent appointment, the same week if possible | Worsening despite treatment may indicate need for a different approach, and catching this early prevents further decline |
| Suicidal thoughts, self-harm urges, psychotic symptoms, serotonin syndrome signs, severe agitation | Seek emergency care immediately: call 988 or go to the nearest emergency department | These are medical emergencies requiring immediate professional intervention |
If you are unsure which category you fall into, err on the side of caution and contact your prescriber. A brief conversation can resolve days of uncertainty and keep you safe.
What to Expect When Starting Medication
One of the most important things I tell new patients is this: side effects can arrive before benefits. Knowing this ahead of time can help you avoid stopping a medication too early.
The Timeline
- First days to weeks: Side effects are often most noticeable early. Common ones vary by medicine and include nausea, sweating, sleep changes, and sexual side effects.[9][10] FDA labels also note that anxiety, agitation, panic attacks, insomnia, irritability, restlessness (akathisia), and, less often, hypomania or mania have been reported in people taking antidepressants, so tell your prescriber about these right away.[11]
- Around 2 weeks: For sertraline, the NHS notes that side effects usually ease after a couple of weeks as your body gets used to the medicine.[24] NICE recommends a first review within 2 weeks, or within 1 week for people aged 18 to 25 or anyone with a particular concern about suicide risk.[2]
- By about 4 weeks: NICE says that if an antidepressant is going to work, its effect is usually seen within 4 weeks, and it recommends reviewing how well treatment is working between 2 and 4 weeks after starting.[2]
- Beyond the first month: Your prescriber can evaluate whether the current medication and dose are achieving adequate symptom control, or whether adjustments are needed.
Many patients start at a lower dose that is increased gradually, and NICE asks prescribers to explain the dose and how it may need to be adjusted.[2] That means the first dose you were prescribed may not be your final dose. Do not decide on your own that the medication "isn't working." If an antidepressant is going to work, an effect is usually seen within 4 weeks, and your prescriber can help judge when a change makes sense.[2]
Discontinuation Syndrome: Why You Should Never Stop Abruptly
This is a topic I feel strongly about, because I have seen patients struggle with it unnecessarily. Antidepressant discontinuation syndrome refers to symptoms that can appear after an antidepressant is stopped, particularly when it is stopped abruptly.[9] It is not the same as addiction. Your body has adapted to the medication's presence, and abrupt removal disrupts that balance.
Symptoms of Discontinuation Syndrome
- Physical symptoms: nausea, sweating, dizziness, tremor, headache, lethargy[9]
- Sensory changes: tingling or other sensory disturbances, including electric shock sensations, and ringing in the ears[9]
- Sleep disturbances: insomnia[9]
- Mood changes: low or unpleasant mood, irritability, agitation, anxiety, confusion, and emotional ups and downs.[9] Withdrawal symptoms can be mistaken for a relapse of the original condition.[22]
- Less common: hypomania and seizures[9]
Not all medications carry equal risk. NICE notes a greater tendency to cause withdrawal symptoms with paroxetine (Paxil) and venlafaxine (Effexor), and advises that antidepressants with a short half-life be tapered more slowly.[8][2] Fluoxetine (Prozac) and its main active metabolite have long elimination half-lives, so dose changes take several weeks to be fully reflected in the body.[11]
The Taper Approach
FDA labeling for antidepressants such as sertraline and paroxetine advises reducing the dose gradually rather than stopping abruptly whenever possible.[9][16] NICE advises reducing the dose in stages, taking into account the medicine's half-life and how long you have taken it, and notes that withdrawal may take weeks or months to complete successfully.[2] The Effexor XR label adds that tapering may need to be individualized and, in some patients, may need to occur over several months.[12]
NICE recommends reducing the dose step by step, each time prescribing a proportion of the previous dose (for example, 50%), and considering smaller reductions (for example, 25%) as the dose gets lower. If very small doses cannot be reached with tablets or capsules, it suggests liquid preparations where available.[2] A 2019 review of PET imaging data on serotonin transporter occupancy argued that SSRIs should be tapered hyperbolically and slowly, down to doses much lower than usual therapeutic minimums, to minimize withdrawal symptoms.[22]
What this means: Always discuss discontinuation with your prescriber before making any changes. If you feel ready to stop your medication, that is a valid conversation to have, and the process of stopping matters as much as the decision itself.
Therapy and Medication Together
Medication is one tool among many. It is an important tool, and sometimes an essential one, but it works best as part of a broader treatment plan that includes psychotherapy, lifestyle modifications, and social support.
The Evidence for Combination Treatment
A 2016 meta-analysis of 13 randomized trials, all using CBT, looked at adding psychotherapy after a person had responded to antidepressant treatment. Adding CBT lowered the risk of relapse or recurrence compared with control conditions (risk ratio 0.78; number needed to treat 8). Among people whose antidepressants were tapered and stopped, those who received CBT were also significantly less likely to relapse (risk ratio 0.67; number needed to treat 5).[20] In the CoBalT trial, people whose depression had not responded to antidepressants and who received CBT alongside usual care had lower depression scores than those receiving usual care alone at a median of 45.5 months, on average 40 months after therapy ended.[21]
Cognitive Behavioral Therapy (CBT)
CBT is among the psychotherapies the APA guideline recommends for adults with depression.[1] It works by helping patients identify and restructure negative thought patterns, develop coping strategies, and gradually confront situations they have been avoiding. For anxiety disorders, the exposure component of CBT is particularly powerful because it teaches the brain that feared situations are manageable, building a new track record of experience that competes with the anxiety-driven narrative.
When Medication Alone Is Appropriate
Not every patient needs or has access to therapy, and medication alone is a reasonable approach in several situations: mild-to-moderate symptoms with good baseline coping skills, limited access to qualified therapists, strong personal preference, and situations where a patient has done extensive therapy in the past and has the skills but needs biological support to use them effectively. NICE lists SSRIs among the first-line options for less severe depression and antidepressant medication among the first-line options for more severe depression, with the choice made together with you.[2]
Red Flags: When to Seek Immediate Help
- Suicidal thoughts or urges to self-harm: even passive thoughts like "everyone would be better off without me" warrant urgent evaluation. This is a medical emergency.
- Psychotic symptoms: hallucinations (hearing or seeing things others don't), delusions, or paranoia in the context of depression require emergency psychiatric evaluation
- Severe agitation or panic: especially if new or much worse after starting or changing a medication. FDA labels list anxiety, agitation, panic attacks, akathisia, hypomania, and mania among symptoms reported in people taking antidepressants.[11]
- Signs of serotonin syndrome: agitation or restlessness, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle twitching or rigidity, heavy sweating, diarrhea, and, in severe cases, high fever or seizures. It is most often caused by combining medications that raise serotonin, and it can also follow a dose increase or a new drug. Severe or rapidly worsening symptoms need emergency treatment.[5]
- New or worsening suicidal thoughts, especially in young adults: antidepressant labels carry a boxed warning that antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. In the label's pooled trial data, there were more cases than with placebo in patients under 18 and those aged 18 to 24, and fewer cases in adults 25 and older.[9] NICE advises monitoring for suicidal thoughts particularly in the early weeks of treatment.[2]
I want to be direct about something: if you are experiencing suicidal thoughts, you are not a burden. You are not broken. You are experiencing a symptom of a treatable medical condition, and there are people trained to help you through it. Reaching out is the right thing to do, and it can save your life.
Crisis Resources: Available 24/7
988 Suicide & Crisis Lifeline: Call or text 988[6]
Crisis Text Line: Text HOME to 741741[26]
Veterans Crisis Line: Dial 988, then press 1, or text 838255[25]
Emergency: Call 911 or go to your nearest emergency department
You are not alone. Trained counselors are available around the clock, every day of the year.
Frequently Asked Questions
NICE advises that treatment might need to be taken for at least 6 months after your symptoms go into remission, with regular reviews.[2] Continuing treatment after full or partial remission may reduce the risk of relapse, and NICE asks clinicians to reach a shared decision about whether to continue based on your clinical needs and preferences.[2] If you have had more than one episode of depression, talk with your prescriber about whether a longer course makes sense for you.
Properly prescribed medication should not change who you are. What patients typically describe is that medication helps lift the weight of depression or quiet the constant noise of anxiety, allowing their actual personality to come through more fully. If you feel emotionally flat, numb, or "not like yourself" on a medication, that is worth discussing with your doctor. It is not an expected outcome, and adjusting the dose or switching medications may help.
NICE asks prescribers to explain how to take an antidepressant safely, including interactions with other medicines and alcohol.[2] Alcohol is a central nervous system depressant, and I generally counsel patients to minimize or avoid it during active treatment. If you also take a benzodiazepine, avoid alcohol entirely: benzodiazepine labeling cautions patients against using alcohol and other central nervous system depressants with these medicines.[19]
Missed-dose advice differs from medicine to medicine, so check the leaflet that came with your prescription or ask your pharmacist. For sertraline, for example, the NHS advises skipping the missed dose, taking your next dose the next day as usual, and not taking 2 doses to make up for a missed one.[24] Some antidepressants, especially paroxetine and venlafaxine, have a greater tendency to cause withdrawal symptoms, so taking them consistently matters.[8] Setting a daily alarm or using a pill organizer can help maintain consistency.
Research suggests St. John's wort may help mild or moderate depression, but it carries real risks. It can weaken the effects of many medicines, including birth control pills, the anti-rejection drug cyclosporine, the blood thinner warfarin, and some antidepressants, and taking it with antidepressants or other drugs that affect serotonin may lead to serious serotonin-related side effects.[23] It is also listed among supplements that can contribute to serotonin syndrome.[5] Unlike prescription drugs, dietary supplements are not approved by the FDA before they are sold.[23] I strongly advise against using St. John's wort without discussing it with your physician first, especially if you take other medications.
It can happen. FDA labels note that anxiety, agitation, panic attacks, insomnia, irritability, and restlessness (akathisia) have been reported in people taking antidepressants, and the boxed warning asks for close monitoring for clinical worsening and suicidal thoughts.[11][9] This is one reason NICE recommends a review within 2 weeks of starting, or within 1 week for people aged 18 to 25.[2] If the increased anxiety is severe, keeps going, or comes with new suicidal thoughts, contact your physician immediately rather than waiting it out.
References
- American Psychological Association (APA). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Approved by the APA Council of Representatives February 2019; page last updated June 2025 (update panel appointed 2025). Accessed November 7, 2026. https://www.apa.org/depression-guideline
- National Institute for Health and Care Excellence (NICE). Depression in Adults: Treatment and Management (NG222), Recommendations. Published 29 June 2022; last reviewed 30 January 2026. Accessed November 7, 2026. https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
- National Institute of Mental Health (NIMH). Major Depression: Statistics. Based on 2021 NSDUH data. Last updated July 2023. Accessed November 7, 2026. https://www.nimh.nih.gov/health/statistics/major-depression
- National Institute of Mental Health (NIMH). Any Anxiety Disorder: Statistics. Based on NCS-R data (2001 to 2003). Accessed November 7, 2026. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder
- Mayo Clinic Staff. Serotonin Syndrome: Symptoms and Causes. Mayo Clinic. September 12, 2024. Accessed November 7, 2026. https://www.mayoclinic.org/diseases-conditions/serotonin-syndrome/symptoms-causes/syc-20354758
- 988 Suicide & Crisis Lifeline. 988 Lifeline home page. Accessed November 7, 2026. https://988lifeline.org/
- Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768-777. doi:10.1016/S0140-6736(18)31793-8. https://pubmed.ncbi.nlm.nih.gov/30712879/
- National Institute for Health and Care Excellence (NICE). Generalised Anxiety Disorder and Panic Disorder in Adults: Management (CG113), Recommendations. Published 26 January 2011; last updated 15 June 2020. Accessed November 7, 2026. https://www.nice.org.uk/guidance/cg113/chapter/Recommendations
- U.S. Food and Drug Administration prescribing information. ZOLOFT (sertraline hydrochloride) tablets and oral solution. Viatris Specialty LLC. DailyMed, revised 8/2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fda754f6-d0f3-4dce-a17a-927d64f912f7
- U.S. Food and Drug Administration prescribing information. LEXAPRO (escitalopram) tablets and oral solution. Allergan, Inc. DailyMed, revised 10/2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13bb8267-1cab-43e5-acae-55a4d957630a
- U.S. Food and Drug Administration prescribing information. PROZAC (fluoxetine hydrochloride) capsules. Dista Products Company. DailyMed, revised 8/2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c88f33ed-6dfb-4c5e-bc01-d8e36dd97299
- U.S. Food and Drug Administration prescribing information. EFFEXOR XR (venlafaxine hydrochloride) extended-release capsules. Viatris Specialty LLC. DailyMed, revised 8/2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c848a5d8-ba94-4c84-80e3-0bf35fb8e32e
- U.S. Food and Drug Administration prescribing information. CYMBALTA (duloxetine delayed-release capsules). Eli Lilly and Company. DailyMed, revised 08/2023. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba
- U.S. Food and Drug Administration labeling. Buspirone hydrochloride tablets. American Health Packaging. DailyMed, published November 2026. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e80d83a6-7c2a-478e-bdf1-c481824fc301
- U.S. Food and Drug Administration prescribing information. WELLBUTRIN XL (bupropion hydrochloride) extended-release tablets. Bausch Health US LLC. DailyMed, revised 11/2025. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21
- U.S. Food and Drug Administration prescribing information. PAXIL (paroxetine hydrochloride) tablets. Apotex Corp. DailyMed, revised 09/2026. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef3b5cbe-f9e1-c1ac-79da-cfe14e3a7e7e
- U.S. Food and Drug Administration prescribing information. SPRAVATO (esketamine) nasal spray. Janssen Pharmaceuticals, Inc. DailyMed, revised 09/2026. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed
- U.S. Food and Drug Administration prescribing information. ABILIFY (aripiprazole) tablets. Otsuka America Pharmaceutical, Inc. DailyMed, revised 1/2025. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac
- U.S. Food and Drug Administration prescribing information. XANAX (alprazolam) tablets. Viatris Specialty LLC. DailyMed, revised 4/2024. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb5cf72e-3a41-41a8-9a38-80f974eca33f
- Guidi J, Tomba E, Fava GA. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature. Am J Psychiatry. 2016;173(2):128-137. doi:10.1176/appi.ajp.2015.15040476. https://pubmed.ncbi.nlm.nih.gov/26481173/
- Wiles NJ, Thomas L, Turner N, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry. 2016;3(2):137-144. doi:10.1016/S2215-0366(15)00495-2. https://pubmed.ncbi.nlm.nih.gov/26777773/
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546. doi:10.1016/S2215-0366(19)30032-X. https://pubmed.ncbi.nlm.nih.gov/30850328/
- National Center for Complementary and Integrative Health (NCCIH). St. John’s Wort. Last updated May 2025. Accessed November 7, 2026. https://www.nccih.nih.gov/health/st-johns-wort
- NHS. How and when to take sertraline. Page last reviewed 8 September 2025. Accessed November 7, 2026. https://www.nhs.uk/medicines/sertraline/how-and-when-to-take-sertraline/
- U.S. Department of Veterans Affairs. Veterans Crisis Line. Accessed November 7, 2026. https://www.veteranscrisisline.net/
- Crisis Text Line. 24/7 Free Confidential Mental Health Support. Accessed November 7, 2026. https://www.crisistextline.org/